These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. cIMP synthesized by sGC as a mediator of hypoxic contraction of coronary arteries. Chen Z; Zhang X; Ying L; Dou D; Li Y; Bai Y; Liu J; Liu L; Feng H; Yu X; Leung SW; Vanhoutte PM; Gao Y Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H328-36. PubMed ID: 24906916 [TBL] [Abstract][Full Text] [Related]
6. Endothelium-Dependent Contractions of Isolated Arteries to Thymoquinone Require Biased Activity of Soluble Guanylyl Cyclase with Subsequent Cyclic IMP Production. Detremmerie CM; Chen Z; Li Z; Alkharfy KM; Leung SW; Xu A; Gao Y; Vanhoutte PM J Pharmacol Exp Ther; 2016 Sep; 358(3):558-68. PubMed ID: 27335436 [TBL] [Abstract][Full Text] [Related]
7. Endothelium-derived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries. Chan CK; Mak J; Gao Y; Man RY; Vanhoutte PM Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2313-21. PubMed ID: 21984543 [TBL] [Abstract][Full Text] [Related]
8. 3',5'-cIMP as Potential Second Messenger in the Vascular Wall. Leung SWS; Gao Y; Vanhoutte PM Handb Exp Pharmacol; 2017; 238():209-228. PubMed ID: 26721675 [TBL] [Abstract][Full Text] [Related]
9. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation. Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063 [TBL] [Abstract][Full Text] [Related]
10. Conventional and Unconventional Mechanisms for Soluble Guanylyl Cyclase Signaling. Gao Y J Cardiovasc Pharmacol; 2016 May; 67(5):367-72. PubMed ID: 26452163 [TBL] [Abstract][Full Text] [Related]
11. Endothelial SIRT1 prevents age-induced impairment of vasodilator responses by enhancing the expression and activity of soluble guanylyl cyclase in smooth muscle cells. Guo Y; Xu C; Man AWC; Bai B; Luo C; Huang Y; Xu A; Vanhoutte PM; Wang Y Cardiovasc Res; 2019 Mar; 115(3):678-690. PubMed ID: 30165439 [TBL] [Abstract][Full Text] [Related]
12. Sodium nitrite causes relaxation of the isolated rat aorta: By stimulating both endothelial NO synthase and activating soluble guanylyl cyclase in vascular smooth muscle. Ling WC; Lau YS; Murugan DD; Vanhoutte PM; Mustafa MR Vascul Pharmacol; 2015 Nov; 74():87-92. PubMed ID: 26044183 [TBL] [Abstract][Full Text] [Related]
13. Biased activity of soluble guanylyl cyclase: the Janus face of thymoquinone. Detremmerie C; Vanhoutte PM; Leung S Acta Pharm Sin B; 2017 Jul; 7(4):401-408. PubMed ID: 28752025 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A suppresses arterial vasoconstriction by regulating calcium sensitization and the endothelium-dependent endothelial nitric oxide synthase/soluble guanylyl cyclase/cyclic guanosine monophosphate pathway: An Hu L; Feng Y; Liu W; Jin L; Nie Z Exp Biol Med (Maywood); 2019 Nov; 244(16):1475-1484. PubMed ID: 31547684 [TBL] [Abstract][Full Text] [Related]
15. PDE1 or PDE5 inhibition augments NO-dependent hypoxic constriction of porcine coronary artery via elevating inosine 3',5'-cyclic monophosphate level. Nan Y; Zeng X; Jin Z; Li N; Chen Z; Chen J; Wang D; Wang Y; Lin Z; Ying L J Cell Mol Med; 2020 Dec; 24(24):14514-14524. PubMed ID: 33169529 [TBL] [Abstract][Full Text] [Related]
16. Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator. Vanhoutte PM; Zhao Y; Xu A; Leung SW Circ Res; 2016 Jul; 119(2):375-96. PubMed ID: 27390338 [TBL] [Abstract][Full Text] [Related]
19. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619 [TBL] [Abstract][Full Text] [Related]
20. Vasomotor control in mice overexpressing human endothelial nitric oxide synthase. van Deel ED; Merkus D; van Haperen R; de Waard MC; de Crom R; Duncker DJ Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1144-53. PubMed ID: 17496213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]